Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.
Tschernia NP, Kumar V, Moore DT, Vincent BG, Coombs CC, Van Deventer H, Foster MC, DeZern AE, Luznik L, Riches ML, Serody JS, Gojo I, Zeidner JF.
Tschernia NP, et al.
Transplant Cell Ther. 2021 Dec;27(12):1021.e1-1021.e5. doi: 10.1016/j.jtct.2021.08.022. Epub 2021 Aug 30.
Transplant Cell Ther. 2021.
PMID: 34474164
Free article.
Clinical Trial.
In the present study, we compared clinical outcomes of 9 patients with AML receiving high-dose cytarabine followed by pembrolizumab in a phase II clinical trial (NCT02768792) prior to alloSCT versus a historical control group of 18 AML patients who underwent alloSCT without prior …
In the present study, we compared clinical outcomes of 9 patients with AML receiving high-dose cytarabine followed by pembrolizumab in a pha …